Arsenic Induces NAD(P)H-quinone Oxidoreductase I by Disrupting the Nrf2·Keap1·Cul3 Complex and Recruiting Nrf2·Maf to the Antioxidant Response Element Enhancer*

The ubiquitous toxic metalloid arsenic elicits pleiotropic adverse and adaptive responses in mammalian species. The biological targets of arsenic are largely unknown at present. We analyzed the signaling pathway for induction of detoxification gene NAD(P)H-quinone oxidoreductase (Nqo1) by arsenic. Genetic and biochemical evidence revealed that induction required cap `n' collar basic leucine zipper transcription factor Nrf2 and the antioxidant response element (ARE) of Nqo1. Arsenic stabilized Nrf2 protein, extending the t½ of Nrf2 from 21 to 200 min by inhibiting the Keap1·Cul3-dependent ubiquitination and proteasomal turnover of Nrf2. Arsenic markedly inhibited the ubiquitination of Nrf2 but did not disrupt the Nrf2·Keap1·Cul3 association in the cytoplasm. In the nucleus, arsenic, but not phenolic antioxidant tert-butylhydroquinone, dissociated Nrf2 from Keap1 and Cul3 followed by dimerization of Nrf2 with a Maf protein (Maf G/Maf K). Chromatin immunoprecipitation demonstrated that Nrf2 and Maf associated with the endogenous Nqo1 ARE enhancer constitutively. Arsenic substantially increased the ARE occupancy by Nrf2 and Maf. In addition, Keap1 was shown to be ubiquitinated in the cytoplasm and deubiquitinated in the nucleus in the presence of arsenic without changing the protein level, implicating nuclear-cytoplasmic recycling of Keap1. Our data reveal that arsenic activates the Nrf2/Keap1 signaling pathway through a distinct mechanism from that by antioxidants and suggest an “on-switch” model of Nqo1 transcription in which the binding of Nrf2·Maf to ARE controls both the basal and inducible expression of Nqo1.

[1]  C. B. Pickett,et al.  Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. , 2003, Annual review of pharmacology and toxicology.

[2]  Jenny R. Roberts,et al.  Accelerated Ovarian Failure Induced by 4-Vinyl Cyclohexene Diepoxide in Nrf2 Null Mice , 2006, Molecular and Cellular Biology.

[3]  Takahiro Shibata,et al.  Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1 , 2006, Molecular and Cellular Biology.

[4]  R. A. Scott,et al.  The Role of Arsenic-Thiol Interactions in Metalloregulation of the ars Operon (*) , 1996, The Journal of Biological Chemistry.

[5]  M. Lieberman,et al.  Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway* , 2005, Journal of Biological Chemistry.

[6]  A. Fairlamb,et al.  Arsenical-resistant trypanosomes lack an unusual adenosine transporter , 1993, Nature.

[7]  J. Mastin Environmental cardiovascular disease , 2007, Cardiovascular Toxicology.

[8]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. B. Pickett,et al.  Nrf2 Controls Constitutive and Inducible Expression of ARE-driven Genes through a Dynamic Pathway Involving Nucleocytoplasmic Shuttling by Keap1* , 2005, Journal of Biological Chemistry.

[10]  C. Tseng Blackfoot Disease and Arsenic: A Never-Ending Story , 2005, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[11]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[12]  Q. Ma,et al.  Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. , 2006, The American journal of pathology.

[13]  R. Lauwerys,et al.  Carcinogenicity, teratogenicity and mutagenicity of arsenic. , 1980, Mutation research.

[14]  M. Golub,et al.  Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. , 1998, Journal of toxicology and environmental health. Part B, Critical reviews.

[15]  J. Lubin,et al.  Relation of arsenic exposure to lung cancer among tin miners in Yunnan Province, China. , 1989, British journal of industrial medicine.

[16]  C. B. Pickett,et al.  The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. , 2004, Free radical biology & medicine.

[17]  M. Kwak,et al.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Ouellette,et al.  New mechanisms of drug resistance in parasitic protozoa. , 1995, Annual review of microbiology.

[19]  E. Carranza,et al.  Arsenic geochemistry and health. , 2005, Environment international.

[20]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[21]  Y. Kan,et al.  An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Fowler,et al.  Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.

[23]  Y. Kan,et al.  Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduc , 2004, The Biochemical journal.

[24]  A. Jaiswal Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression. , 1994, Pharmacogenetics.

[25]  K. G. Brown,et al.  Inorganic arsenic: a need and an opportunity to improve risk assessment. , 1997, Environmental health perspectives.

[26]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[27]  P. Talalay,et al.  Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. B. Pickett,et al.  Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription* , 2002, The Journal of Biological Chemistry.

[29]  Qiang Ma,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Degradation of Aryl Hydrocarbon Receptor (AhR) by the Ubiquitin-Proteasome Pathway , 2000, The Journal of Biological Chemistry.

[30]  C. B. Pickett,et al.  Transcriptional Regulation of the Antioxidant Response Element , 2000, The Journal of Biological Chemistry.

[31]  M. Tallman,et al.  The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. , 2004, Leukemia research.

[32]  M. Montano,et al.  Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. , 2005, The Biochemical journal.

[33]  A. Santamaria,et al.  Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. , 1988, Analytical biochemistry.

[34]  Wei Qu,et al.  Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. , 2003, Experimental cell research.

[35]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[36]  Eric D. Wieben,et al.  Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics , 2006, Journal of Biological Chemistry.

[37]  E. Farber History of the treatment of psoriasis. , 1992, Journal of the American Academy of Dermatology.

[38]  E. S. Hunter,et al.  Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. , 1996, Toxicology and applied pharmacology.

[39]  W. Cullen,et al.  Methylated trivalent arsenic species are genotoxic. , 2001, Chemical research in toxicology.